ArticleBone marrow transplantation2024

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.

Ruth M de Tute et al.PubMed ↗Publisher ↗

No numbers read from the abstract.